Cargando…

Modulation of valosin-containing protein by Kyoto University Substances (KUS) as a novel therapeutic strategy for ischemic neuronal diseases

Retinal ischemia causes several vision-threatening diseases, including diabetic retinopathy, retinal artery occlusion, and retinal vein occlusion. Intracellular adenosine triphosphate (ATP) depletion and subsequent induced endoplasmic reticulum (ER) stress are proposed to be the underlying mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hata, Masayuki, Ikeda, Hanako Ohashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607815/ https://www.ncbi.nlm.nih.gov/pubmed/28966635 http://dx.doi.org/10.4103/1673-5374.213540

Ejemplares similares

KUS121, a valosin-containing protein modulator, attenuates ischemic stroke via preventing ATP depletion
por: Kinoshita, Hisanori, et al.
Publicado: (2019)

KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress
por: Hata, Masayuki, et al.
Publicado: (2017)

Neuoroprotective efficacies by KUS121, a VCP modulator, on animal models of retinal degeneration
por: Hasegawa, Tomoko, et al.
Publicado: (2016)

Involvement of endothelins in neuroprotection of valosin-containing protein modulators against retinal ganglion cell damage
por: Kusaka, Mami, et al.
Publicado: (2022)

De Kus /
por: Gershten, Donna M.
Publicado: (2002)

KUS121, an ATP regulator, mitigates chorioretinal pathologies in animal models of age-related macular degeneration
por: Muraoka, Yuki, et al.
Publicado: (2018)

KUS121 attenuates the progression of monosodium iodoacetate-induced osteoarthritis in rats
por: Iwai, Sachiko, et al.
Publicado: (2021)

Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial
por: Ikeda, Hanako Ohashi, et al.
Publicado: (2020)

A VCP modulator, KUS121, as a promising therapeutic agent for post-traumatic osteoarthritis
por: Saito, Motoo, et al.
Publicado: (2020)

Author Correction: A VCP modulator, KUS121, as a promising therapeutic agent for post-traumatic osteoarthritis
por: Saito, Motoo, et al.
Publicado: (2021)

Valosin Containing Protein (VCP): A Multistep Regulator of Autophagy
por: Ferrari, Veronica, et al.
Publicado: (2022)

Valosin-Containing Protein/p97 as a Novel Therapeutic Target in Acute Lymphoblastic Leukemia
por: Gugliotta, Gabriele, et al.
Publicado: (2017)

Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer †
por: Costantini, Susan, et al.
Publicado: (2021)

Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease
por: Ju, Jeong-Sun, et al.
Publicado: (2009)

Valosin-Containing Protein Gene Mutations: Cellular Phenotypes Relevant to Neurodegeneration
por: Poksay, Karen S., et al.
Publicado: (2011)

Heterozygous mutations in valosin-containing protein (VCP) and resistance to VCP inhibitors
por: Bastola, Prabhakar, et al.
Publicado: (2019)

Pathogenic variants of Valosin-containing protein induce lysosomal damage and transcriptional activation of autophagy regulators in neuronal cells
por: Ferrari, Veronica, et al.
Publicado: (2022)

Involvement of Peripheral and Central Nervous Systems in a Valosin-Containing Protein Mutation
por: Segers, Kurt, et al.
Publicado: (2014)

Lysine Methylation of the Valosin-Containing Protein (VCP) Is Dispensable for Development and Survival of Mice
por: Fusser, Markus, et al.
Publicado: (2015)

Novel genomic targets of valosin-containing protein in protecting pathological cardiac hypertrophy
por: Zhou, Ning, et al.
Publicado: (2020)

Clinical Classification of Variants in the Valosin-Containing Protein Gene Associated With Multisystem Proteinopathy
por: Schiava, Marianela, et al.
Publicado: (2023)

Cardioprotective Effects of VCP Modulator KUS121 in Murine and Porcine Models of Myocardial Infarction
por: Ide, Yuya, et al.
Publicado: (2019)

Valosin-Containing Protein (VCP/p97) Is an Activator of Wild-Type Ataxin-3
por: Laço, Mário N., et al.
Publicado: (2012)

Valosin-containing protein regulates the proteasome-mediated degradation of DNA-PKcs in glioma cells
por: Jiang, N, et al.
Publicado: (2013)

The valosin‐containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload
por: Zhou, Ning, et al.
Publicado: (2017)

Retinoid receptor turnover mediated by sumoylation, ubiquitination and the valosin-containing protein is disrupted in glioblastoma
por: Rodriguez, Virginia, et al.
Publicado: (2019)

The Biogenesis of Dengue Virus Replication Organelles Requires the ATPase Activity of Valosin-Containing Protein
por: Mazeaud, Clément, et al.
Publicado: (2021)

Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy
por: Korb, Manisha, et al.
Publicado: (2022)

Valosin containing protein (VCP): initiator, modifier, and potential drug target for neurodegenerative diseases
por: Chu, Siwei, et al.
Publicado: (2023)

A survey of attitudes toward clinical research among physicians at Kyoto University Hospital
por: Sumi, Eriko, et al.
Publicado: (2009)

Mutations in valosin-containing protein (VCP) decrease ADP/ATP translocation across the mitochondrial membrane and impair energy metabolism in human neurons
por: Ludtmann, Marthe H. R., et al.
Publicado: (2017)

Response: Naoko Saito, Finding as Founding: Rejoinder to René Arcilla’s Review, Naoko Saito, Associate Professor of Education at Kyoto University, Japan. Kyoto University, Yoshidahonmachi, Sakyo-ku, Kyoto 606-8501
por: Saito, Naoko
Publicado: (2020)

The valosin-containing protein is a novel mediator of mitochondrial respiration and cell survival in the heart in vivo
por: Lizano, Paulo, et al.
Publicado: (2017)

Targeting valosin‐containing protein enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma
por: Luo, Hui, et al.
Publicado: (2019)

Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing Dogs
por: LeBlanc, Amy K., et al.
Publicado: (2022)

Accelerator-driven system at Kyoto University Critical Assembly
por: Pyeon, Cheol
Publicado: (2021)

Acute development of collateral circulation and therapeutic prospects in ischemic stroke
por: Iwasawa, Eri, et al.
Publicado: (2016)

Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant
por: Ayaki, Takashi, et al.
Publicado: (2014)

Protein kinase A inhibition facilitates the antitumor activity of xanthohumol, a valosin‐containing protein inhibitor
por: Shikata, Yuki, et al.
Publicado: (2017)

The AAA + ATPase valosin-containing protein (VCP)/p97/Cdc48 interaction network in Leishmania
por: Aguiar, Bruno Guedes, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5n1v3ak5c1e56b3f1g1phig158